YOLFTbeta
Medios AG

Medios AG

0QB4 · LSE

10.88EUR-0.36 (-3.20%)

Price History

Full chart

Market Stats

Previous Close11.24
Open10.82
Day Range10.82 – 10.88
52-Week Range10.00 – 17.44
Volume2
Market Cap196.00M
P/E (TTM)0.25
Forward P/E0.00
EPS0.451
Dividend Yield0.00%
Beta1.30
50-Day Avg14.95
200-Day Avg15.75

About

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG was founded in 2015 and is headquartered in Berlin, Germany.

Company Details

  • CEOMr. Thomas Meier
  • Employees989
  • HeadquartersHeidestrasse 9, Berlin, Germany, 10557, UK
  • Websitehttps://www.medios.ag

Leadership

  • Mr. Christoph PrusseitChief Business Officer of Germany & Member of Executive Board · b. 1988
  • Mr. Constantijn van RietschotenChief Business Officer of International and Member of Executive Board · b. 1970
  • Mr. Thomas MeierCEO & Member of Executive Board · b. 1968
  • Mr. Stefan BauerreisCFO & Member of the Executive Board · b. 1972
  • Ms. Katrin Yvonne NeufferDirector Investor Relations & Communications · b. 1977

Financials

Income Statement

Currency: EUR2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.04M1.38M35.22K326.114.48K58.22M133.21M253.64M327.83M516.80M626.54M1.36B1.61B1.78B1.88B2.08B
Growth (%)-+32.52%-97.44%-99.07%+1274.92%+1298363.79%+128.81%+90.40%+29.25%+57.64%+21.23%+116.65%+18.67%+10.80%+5.51%+10.39%
Cost of Revenue-297.83K1.09M---56.69M132.84M243.23M315.62M496.34M607.81M1.33B1.56B1.68B1.82B1.99B
Gross Profit1.34M287.61K35.22K326.114.48K1.53M374.00K10.40M12.21M20.46M18.73M27.05M50.86M108.63M68.03M91.93M
Gross Margin128.70%20.92%100.00%100.00%100.00%2.62%0.28%4.10%3.72%3.96%2.99%1.99%3.16%6.09%3.61%4.42%
Operating Expense-1.10M257.76K239.01K165.49K37.62K364.00K941.00K3.14M5.13M6.65M9.66M13.40M24.02M77.25M39.48M50.20M
Operating Income2.44M29.85K-203.79K-165.16K-33.13K1.16M-567.00K7.26M7.08M13.81M9.07M13.64M26.84M31.37M28.56M41.73M
Operating Margin234.95%2.17%-578.54%-50645.58%-738.99%2.00%-0.43%2.86%2.16%2.67%1.45%1.01%1.67%1.76%1.52%2.01%
EBITDA-165.16K59.38K-189.89K-149.76K-32.86K1.10M-734.49K7.29M8.56M16.40M13.12M34.68M51.33M50.73M64.00M79.59M
EBITDA Margin-15.92%4.32%-539.09%-45922.23%-732.83%1.89%-0.55%2.87%2.61%3.17%2.09%2.55%3.19%2.84%3.40%3.83%
Net Income---203.79K-165.16K-33.17K739.00K-3.17M4.13M4.33M9.76M5.53M7.40M18.33M18.81M12.55M15.37M
Net Income Margin---578.54%-50645.54%-739.68%1.27%-2.38%1.63%1.32%1.89%0.88%0.55%1.14%1.05%0.67%0.74%
R&D--------90.00K428.00K------
R&D as % of Total Revenue--------0.03%0.08%------
Interest Expense1.28M9.63K11.12K98.42276.21.52K1.29M96.49K35.06K193.90K671.00K1.73M1.26M2.41M10.86M19.12M
Interest Expense % of Total Revenue123.31%0.70%31.56%30.18%6.16%0.00%0.97%0.04%0.01%0.04%0.11%0.13%0.08%0.13%0.58%0.92%

Balance Sheet

Currency: EUR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.46M859.39K657.48K441.11K234.35K89.78K4.80M47.86M61.71M98.42M116.57M194.54M524.14M575.96M594.75M934.36M903.04M
Total Liabilities-2.92M518.32K280.72K268.14K226.54K89.78K3.48M13.76M16.03M27.92M34.94M52.11M129.98M127.91M125.95M424.17M388.82M
Total Equity921.00K341.07K376.75K172.97K7.81K-1.32M32.12M45.68M70.50M81.63M142.43M394.16M448.05M468.81M510.19M514.22M
Cash58.00K55.62K12.06K180.638.41K20.83K1.21M17.09M16.69M11.77M15.62M19.79M168.43M79.21M71.04M106.00M81.84M
Total Debt256.00K253.45K128.87K------203.17K6.24M19.23M49.71M17.55M17.14M242.43M188.89M
Net Debt198.00K197.83K116.81K-180.63-8.41K-20.83K-1.21M-17.09M-16.69M-11.57M-9.38M-554.00K-118.72M-61.66M-53.90M136.43M107.05M

Cash Flow

Currency: EUR2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.70K-80.60K21.22K103.36K13.30K1.30M-1.58M727.00K-3.16M-620.44K-38.93M60.23M35.59M16.41M64.69M43.00M
Investing Cash Flow21.30K156.50K-123.49-123.37--119.00K-373.00K-16.01M-1.82M2.17M-5.91M17.32M-86.65M-16.57M-223.33M-4.78M
Financing Cash Flow-1.40K-119.40K22.09K-94.08K-88025.00K17.74M14.88M-135.96K-468.89K51.98M71.09M-38.15M-8.01M193.82M-62.60M
Capital Expenditure17.40K3.50K123.49208.370119.00K373.00K5.34M1.82M2.09M4.86M12.82M5.06M1.21M4.74M6.07M
Free Cash Flow-21.10K-84.10K21.10K103.15K13.30K1.18M-1.96M-4.61M-4.98M-2.71M-43.79M47.41M30.52M15.20M59.95M36.94M
Dividends Paid----------52.32M71.84M----
FCF to OCF570.27%104.34%99.42%99.80%100.00%90.85%123.53%-634.66%157.81%436.75%112.49%78.71%85.77%92.64%92.68%85.90%
Dividend Paid to FCF-----------119.46%151.52%----

Earnings

Report DateMar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 27, 2024May 7, 2024Aug 13, 2024Nov 12, 2024Mar 25, 2025May 5, 2025Aug 13, 2025Nov 11, 2025Mar 26, 2026May 12, 2026Aug 12, 2026Nov 10, 2026
EPS Estimate-----------------------
EPS Actual0.140.170.17-0.110.210.210.250.100.200.190.300.100.170.100.160.080.250.250.29-0.190.200.14-
Surprise-----------------------
Timing-----------Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap196.00M
Enterprise Value391.53M
Trailing P/E0.25
Forward P/E0.00
Price / Sales0.09
Price / Book0.00
EPS0.451
Book Value21.35
Revenue (TTM)2.16B
Gross Profit (TTM)198.50M
EBITDA69.70M
Profit Margin0.52%
Operating Margin1.64%
Return on Equity2.14%
Return on Assets2.64%
Shares Outstanding13.66M
Shares Float8.34M
Beta1.30
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%